Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Hashrate infrastructure project Cysic's market cap surpasses 580 millions USD, reaching a new all-time high with a 15% increase in the past 24 hours.

Hashrate infrastructure project Cysic's market cap surpasses 580 millions USD, reaching a new all-time high with a 15% increase in the past 24 hours.

ChaincatcherChaincatcher2026/03/10 10:34
Show original

According to ChainCatcher, data from CoinMarketCap shows that the current price of $CYS is $0.5815, with an FDV of $580M. The price has increased by approximately 15% in the past 24 hours, with a 24-hour trading volume of $38M and a 7-day increase of 82%.

Since the token launch, Cysic has become an important project in the ZK computing power infrastructure sector.

It is reported that Cysic has already provided proof acceleration services for several ZK projects, achieving real and sustainable positive cash flow, with its business model validated. At the same time, the Cysic AI product is about to be launched, with plans to introduce inference services, an Agent marketplace, a Skills store, and Agent hosting services.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Dental treatment company vVardis has announced the terms for its $214 million US IPO.

智通财经•2026/11/09 06:41
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

智通财经•2026/11/09 06:41
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss